
Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer. Leveraging the GPS platform, they are building a pipeline of tumor-selective cytokine and checkpoint inhibitor immuno... Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer. Leveraging the GPS platform, they are building a pipeline of tumor-selective cytokine and checkpoint inhibitor immunotherapies to treat cancer. The goal is to overcome the limitations of current I-O therapies by developing products with an improved therapeutic index. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0563 | -7.2355738337 | 0.7781 | 0.816 | 0.7101 | 223984 | 0.7695995 | CS |
4 | -0.2332 | -24.4188481675 | 0.955 | 0.9998 | 0.7101 | 485616 | 0.83836532 | CS |
12 | -0.2562 | -26.1963190184 | 0.978 | 1.7 | 0.63 | 4155506 | 1.36670765 | CS |
26 | -0.0482 | -6.25974025974 | 0.77 | 1.7 | 0.63 | 2135025 | 1.33760164 | CS |
52 | 0.0708 | 10.8755760369 | 0.651 | 1.93 | 0.58 | 1427198 | 1.29935662 | CS |
156 | -6.2782 | -89.6885714286 | 7 | 8.0995 | 0.49 | 523108 | 1.36958222 | CS |
260 | -14.2782 | -95.188 | 15 | 27.95 | 0.49 | 470443 | 1.72409271 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales